COVID19 KOD TRUDNICA
Ključne reči:
COVID19, trudnoća, novorođenčeApstrakt
Od kada je marta 2020.godine prvi put identifikovan novi virus SARS CoV2 i pandemija nastavila globalno da se širi, povećavao se broj zaraženih i trudnica koje su zahtevale hospitalno lečenje, kao i lečenje u jedinicama intenzivne nege. Prema do sada objavljenim studijama i kliničkom iskustvu COVID19 u trudnoći je povezan sa brojnim negativnim maternalnim, fetalnim i neonatalnim ishodima. Fiziološke promene koje se dešavaju u trudnoći, pre svega na nivou imunskog sistema su ključne za što bolje razumevanje patogeneze i kliničke slike COVID19 infekcije u trudnoći. COVID19 se sa majke na novorođenče može preneti na intrauterino, intrapartalno i postpartalno (u direktnom kontaktu ili putem dojenja). Iako se dugo smatralo da nije moguća vertikalna transmisija, virus je izolovan sa fetalne strane placente. Studije su pokazale da su komplikacije u trudnoći i intrapartalno bile značajno češće kod simptomatskih COVID19 pozitivnih trudnica. Lečenje trudnica se ne razlikuje suštinski, iako su studije pokazale značajno veću incidencu hospitalizacije i potrebe za lečenjem u jedinicama intenzivne nege kada su u pitanju žene u trudnoći u odnosu na opštu populaciju žena istih demografskih karakteristika i zdravstvenog stanja. Brojne studije su pokazale da trudnoća sama po sebi predstavlja stanje povećanog rizika za kompikacije vezane za COVID19 iz tog razloga potreban je pojačan nadzor trudnica i prevencija oboljevanja u ovoj posebno vulnerabilnoj kategoriji. Do sada registrovane vakcine su najbolja specifična mera prevencije COVID19 infekcije u trudnoći. Štiteći trudnice štitimo i zdravlje njihovig potomstva.
Reference
Joseph NT, Stanhope KK, Badell ML, Horton JP, Boulet SL, Jamieson DJ. Socio- demographic predictors of SARS-CoV-2 infec- tion in obstetric patients, Georgia, USA. Emerg Infect Dis 2020;26:2787–9.
Badr DA, Mattern J, Carlin A, et al. Are clinical outcomes worse for pregnant women at !20 weeks’ gestation infected with coro- navirus disease 2019? A multicenter case- control study with propensity score match- ing. Am J Obstet Gynecol 2020;223:764–8.
Zambrano LD, Ellington S, Strid P, et al. Up- date: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status— United States, January 22eOctober 3, 2020. MMWR Morb Mortal Wkly Rep 2020;69: 1641–7.
Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national popula- tion based cohort study. BMJ 2020;369: m2107.
Afshar Y, Gaw SL, Flaherman VJ, et al. Clinical presentation of coronavirus disease 2019 (COVID-19) in pregnant and recently pregnant people. Obstet Gynecol 2020;136: 1117–25.
Vivanti AJ, Vauloup-Fellous C, Prevot S, et al. Transplacental transmission of SARS-CoV- 2 infection. Nat Commun 2020;11:3572.
World Health Organization. Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2 scientific brief, 8 February 2021. 2021. Available at: https://apps. who.int/iris/handle/10665/339422. Accessed February 24, 2022.
Mofenson LM, Idele P, Anthony D, et al. The evolving epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young people. 2020. Available at: https:// www.unicef-irc.org/publications/pdf/Evolving- Epidemiologic-Clinical-Picture-SARS-CoV2- COVID-19-Children-Young-People.pdf. Accessed February 24, 2022.
Edlow AG, Li JZ, Collier AY, et al. Assess- ment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020;3:e2030455.
Groß R, Conzelmann C, Müller JA, et al. Detection of SARS-CoV-2 in human breastmilk. Lancet 2020;395:1757–8.
Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-anal- ysis. CMAJ 2021;193:E540–8.
A.M. Ciobanu, S. Colibaba, B. Cimpoca, G. Peltecu, A.M. PanaitescuThrombocytopenia in pregnancyMaedica (Bucur), 2016:11,55-60.
C.J. Lockwood, C.F. Yen, M. Basar, U.A. Kayisli, M. Martel, I. Buhimschi, C. Buhimschi, S.J. Huang, G. Krikun, F. SchatzPreeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cellsAm. J. Pathol., 172 (2008:172, 1571-1579, 10.2353/ajpath.2008.070629.
S. Figliozzi, P.G. Masci, N. Ahmadi, L. Tondi, E. Koutli, A. Aimo, K. Stamatelopoulos, M.A. Dimopoulos, A.L.P. Caforio, G. GeorgiopoulosPredictors of adverse prognosis in COVID-19: a systematic review and meta-analysisEur. J. Clin. Invest., 2020:50 Article e13362, 10.1111/eci.13362
G. Lippi, M. Plebani, B.M. Henry. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysisClin. Chim. Acta, 506 (2020), pp. 145-148, 10.1016/j.cca.2020.03.022
M. Mendoza, I. Garcia-Ruiz, N. Maiz, C. Rodo, P. Garcia-Manau, B. Serrano, R. Lopez-Martinez, J. Balcells, N. Fernandez-Hidalgo, E. Carreras, A. SuyPre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational studyBJOG An Int. J. Obstet. Gynaecol., 2020:117, 1374-1380, 10.1111/1471-0528.16339
D. Rolnik. Can COVID-19 in pregnancy cause pre-eclampsia?BJOG An Int. J. Obstet. Gynaecol., 2020:127,1381-1381.
P. Dubey, S.Y. Reddy, S. Manuel, A.K. Dwivedi. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol., 252 2020: 252, 490-501.
Metz TD, Clifton RG, Hughes BL, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol 2021;137: 571–80.
Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health 2021;9:e759–72.
Graham WJ, Afolabi B, Benova L, et al. Protecting hard-won gains for mothers and newborns in low-income and middle-income countries in the face of COVID-19: call for a service safety net. BMJ Glob Health 2020;5: e002754.
M. Delahoy, M. Whitaker, A. O’Halloran, e. al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19 — COVID-NET, 13 statesH.a.H. Services (2020)1347-1354.
M.C. Smithgall, X. Liu-Jarin, D. Hamele-Bena, A. Cimic, M. Mourad, L. Debelenko, X. Chen. Third-trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive women: histomorphology, including viral immunohistochemistry and in-situ hybridization. Histopathology (2020), 10.1111/his.14215
J. Yan, J. Guo, C. Fan, J. Juan, X. Yu, J. Li, L. Feng, C. Li, H. Chen, Y. Qiao, D. Lei, C. Wang, G. Xiong, F. Xiao, W. He, Q. Pang, X. Hu, S. Wang, D. Chen, Y. Zhang, L.C. Poon, H. Yang. Coronavirus disease 2019 in pregnant women: a report based on 116 casesAm. J. Obstet. Gynecol., 223 (2020), 10.1016/j.ajog.2020.04.014
R. Gajbhiye, D. Modi, S. Mahale. Pregnancy outcomes, Newborn complications and Maternal-Fetal Transmission of SARS-CoV-2 in women with COVID-19: a systematic review of 441 casesmedRxiv (2020), p. 2020, 10.1101/2020.04.11.200623562004.2011.20062356.
D. Benhamou, H. Keita, A.S. Ducloy-Bouthors. Coagulation changes and thromboembolic risk in COVID-19 obstetric patientsAnaesth Crit Care Pain Med, 39 (2020), pp. 351-353,
S. Figliozzi, P.G. Masci, N. Ahmadi, L. Tondi, E. Koutli, A. Aimo, K. Stamatelopoulos, M.A. Dimopoulos, A.L.P. Caforio, G. Georgiopoulos. Predictors of adverse prognosis in COVID-19: a systematic review and meta-analysisEur. J. Clin. Invest., 50 (2020), Article e13362, 10.1111/eci.13362
C. Graham, R. Chooniedass, W.P. Stefura, A.B. Becker, M.R. Sears, S.E. Turvey, P.J. Mandhane, P. Subbarao, K.T. HayGlassIn vivo immune signatures of healthy human pregnancy: inherently inflammatory or anti-inflammatory?PloS One, 12 (2017), Article e0177813, 10.1371/journal.pone.0177813
T. Herold, V. Jurinovic, C. Arnreich, B.J. Lipworth, J.C. Hellmuth, M. von Bergwelt-Baildon, M. Klein, T. Weinberger. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19J. Allergy Clin. Immunol., 146 (2020), pp. 128-
C.J. Lockwood, C.F. Yen, M. Basar, U.A. Kayisli, M. Martel, I. Buhimschi, C. Buhimschi, S.J. Huang, G. Krikun, F. SchatzPreeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cellsAm. J. Pathol., 172 (2008), pp. 1571-1579
National Institutes of Health. Coronavirus disease 2019 treatment guidelines. 2021. Accessed. Available at: https://www.covid19 treatmentguidelines.nih.gov/. Accessed February 24 2022.
SMFM. Management consideration s for pregnant patients with COVID-19. 2021. Avail- able at: https://www.smfm.org/covidclinical. Accessed February 24 2022.
